BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Moraga Biotechnology Corporation Release: Primitive Adult Stem Cells Found In Peripheral Blood


4/17/2006 10:32:35 AM

LOS ANGELES, April 17 /PRNewswire/ -- Moraga Biotechnology Corporation, an adult stem cell company based in Los Angeles, California, announces the discovery of its proprietary Blastomere-Like Stem Cells (BLSCs) circulating in the peripheral blood of mammals. The Company's scientists found that these adult stem cells were able to differentiate into most tissues and organs of the body.

The Company's scientists have developed a proprietary and cost-effective method for isolating and purifying large numbers of its primitive embryonic- like stem cells from the blood without ex vivo expansion. Moraga recently announced that its BLSCs were found in large numbers throughout the body. The Company believes this new discovery is a major breakthrough for finding large numbers of primitive adult stem cells circulating in the blood.

Moraga's chief executive, Dr. John F. Wong, noted that the ability to isolate these primitive embryonic-like stem cells in peripheral blood allows the Company to enter the stem cell banking business in the near future. With this new method for isolating stem cells, the Company will be able to bank an individual's stem cells by simply withdrawing a sample of their blood. The Company intends in the very near future to establish processing centers to which a donor's blood sample is shipped; the blood is processed; and, the stem cells are isolated. The BLSCs are then stored at the center for future therapeutic and diagnostic use. Dr. Wong further stated that "by circumventing the expensive process of isolating and expanding the stem cells outside the body, the Company can now travel down a shorter path towards developing a near-term solution for autologous stem cell-based therapies, from which its BLSCs may be used for treating various forms of diseases such as heart attacks, Parkinson's disease and stroke."

For more information on Moraga Biotechnology Corp. please visit http://www.moragabiotech.com . Contact: John F. Wong (310) 440-0374 jwong@moragabiotech.com

Moraga Biotechnology Corporation

CONTACT: John F. Wong of Moraga Biotechnology Corp., +1-310-440-0374,jwong@moragabiotech.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES